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APC = activated protein C; PC = protein C.
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Abstract
Acute pancreatitis is a local inflammatory process that leads to a
systemic inflammatory response in the majority of cases, and
sometimes leads to multiple organ failure. It is obvious that
coagulation and especially the protein C system are involved in this
disease. The present commentary is related to a study in patients with
pancreatitis with and without multiple organ failure in which protein C
and activated protein C levels were studied. The protein C system
and other studies analyzing (activated) protein C levels are discussed.
Introduction
In the present issue of Critical Care, the Finnish group of
Lindstrom and colleagues [1] describes a study in 31
patients with acute pancreatitis in which they assess the
organ function and analyze the levels of protein C (PC) and
activated protein C (APC), as well as the monocyte activation
state, in order to evaluate the turnover of PC to APC. They
categorized the patients into a group (n = 13) with severe
acute pancreatitis with multiple organ failure and a control
group (n = 18) with severe acute pancreatitis without multiple
organ failure. In the group with multiple organ failure, the
number of patients with decreased (<70% of the adult mean)
levels of PC was significantly higher than in the group without
multiple organ failure (92% versus 44%, P < 0.008).
Although within normal limits, in all but one patient the
minimum APC level was lower in cases with multiple organ
failure than in controls (median 84.9% versus 96.5%,
P = 0.009). Strikingly, samples in five patients were taken
preceding multiple organ failure and showed low PC levels
and high APC/PC ratios. The percentage of HLA-DR-positive
monocytes correlated weakly with the PC and APC levels
(r = 0.38 and r = 0.27, respectively).
Protein C pathway
The PC system has been extensively studied, not only
because the decreased function of this natural anticoagulant
pathway may be particularly problematic leading to thrombo-
sis, but also because of the other properties of the PC system.
APC, and probably also PC, has specific immunomodulating
properties: in vitro, APC inhibits tumor necrosis factor alpha
elaboration from monocytes and blocks leukocyte adhesion to
selectins, as well as influences apoptosis [2].
The PC pathway is initiated when thrombin binds to
thrombomodulin on the surface of the endothelium. An
endothelial cell PC receptor augments PC activation by the
thrombin–thrombomodulin complex more than 10-fold in vivo.
The endothelial cell PC receptor is shed from the
endothelium by inflammatory mediators and thrombin. The
exact function and properties of this soluble endothelial cell
PC receptor are not known. The endothelial cell PC receptor
can undergo translocation from the plasma membrane to the
nucleus, where it redirects gene expression. During
translocation it can carry APC to the nucleus, possibly
accounting for the ability of APC to modulate inflammatory
mediator responses in the endothelium [2].
The third important property of APC is the influence on
fibrinolysis. APC is capable of neutralizing the fibrinolysis
inhibitors plasminogen activator inhibitor 1 and thrombin
activatable fibrinolysis inhibitor [3,4]. During acute
inflammation and sepsis there is activation of coagulation,
leading to the formation of thrombin being the trigger for the
activation of PC to APC. High levels of thrombin lead to high
levels of APC, which will complex to plasminogen activator
inhibitor 1 or will be neutralized. Finally the level of PC will
decrease, or there may even be a depletion of PC as can be
seen in meningococcal sepsis.
Levels of protein C and activated protein C in
acute disease
Levels of PC have been studied extensively in several clinical
situations, especially during meningococcal sepsis, but also
during other forms of sepsis [5]. Of interest is the study in
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neutropenic patients with fever in which serial blood samples
were taken. In those patients who developed sepsis, the
clinical symptoms were preceded with a decline of their PC
levels [6]. The same feature was found in the pancreatitis
study of Lindstrom and colleagues [1].
APC levels have been studied less extensively, for several
reasons. Measuring APC has only recently been feasible
using an enzyme capture assay [7] requiring benzamidine as
a special inhibitor during sampling, and the assay is time
consuming (2 weeks) — although there is a new assay
described using much less time [8]. Besides these technical
specialties, the half-life of APC is about 15 min so just the
level of APC is useless without other markers of coagulation
and inflammation at the same time for analysis. The first
studies were in healthy individuals [9], individuals with brain
infarction, and smokers versus nonsmokers [10].
The results of the studies of APC levels in human sepsis are
not all that obvious and may even seem contradictory. In the
study of de Kleijn and colleagues in children with meningo-
coccal sepsis, the APC levels paralleled thrombin markers
and were positively related to severity with the highest levels
in nonsurvivors [11]. In the study of Liaw and colleagues [8],
from the 32 patients with severe sepsis studied, 20 patients
had APC levels that paralleled thrombin markers and 12
patients did not, indicating an impaired PC activation. Severe
sepsis is an extremely heterogeneous condition, and the
factors involved in downregulation of the endothelium-based
PC activation in patients remain to be identified, but severity
of disease, age, cigarette smoking and pre-existing conditions
are known to be among these factors.
Limits of this study
Acute pancreatitis is a local inflammatory process that leads
to a systemic inflammatory response in the majority of cases,
and sometimes to multiple organ failure. In the present study
of Lindstrom and colleagues [1] a small number of patients
were analyzed. The relevance of studying PC and APC in this
disease is certainly valid and supported by animal
experiments [12]. The units in which APC was expressed are
not very common, and make it difficult to compare the results
with other studies. The differences between cases and
controls are not dramatically clinically significant. The results
on HLA-DR are not very well elaborated.
Nowadays the level of 30% HLA-DR-positive cells is
considered a cutoff level for categorizing immune depression
or not. It would have been interesting to categorize on the
basis of that level and to analyze the APC and PC levels and
ratios. On the other hand, we need these kinds of studies to
determine the exact role of APC and PC in severe sepsis and
the possible therapeutic role of PC and APC supplementation.
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